What's in Martin Blomberg Jensen's pipeline?

Martin Blomberg Jensen has 2 drugs in our index: 1 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Martin Blomberg Jensen's portfolio?

Top competitors by shared drug class: Actavis Inc., Bayer, Dr. August Wolff GmbH & Co. KG Arzneimittel, Hatice Tukenmez Kurnaz, Johns Hopkins University.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/martin-blomberg-jensen.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Martin Blomberg Jensen — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Martin Blomberg Jensen pipeline: 1 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
human chorionic gonadotropin	human chorionic gonadotropin	marketed	Gonadotropin; LH analog	Luteinizing hormone receptor (LHCGR)	Reproductive/Endocrinology
Estradiol (E2)	Estradiol (E2)	phase 3	Estrogen receptor agonist	Estrogen receptor alpha (ERα), Estrogen receptor beta (ERβ)	Endocrinology

Therapeutic area mix

Endocrinology · 1
Reproductive/Endocrinology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Actavis Inc. · 1 shared drug class
Bayer · 1 shared drug class
Dr. August Wolff GmbH & Co. KG Arzneimittel · 1 shared drug class
Hatice Tukenmez Kurnaz · 1 shared drug class
Johns Hopkins University · 1 shared drug class
TriHealth Inc. · 1 shared drug class
farzaneh hojjat · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Martin Blomberg Jensen:

Cite this brief

Drug Landscape (2026). Martin Blomberg Jensen — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/martin-blomberg-jensen. Accessed 2026-05-16.